Induction therapy with interleukin-2 receptor antagonist after intestinal transplantation is associated with reduced acute cellular rejection and improved renal function

D. G. Farmer, S. V. McDiarmid, S. Edelstein, J. F. Renz, G. Hisatake, G. Cortina, C. Fondevila, M. Correa, S. Rhodes, A. Zafar, Y. Chavez, H. Yersiz, R. W. Busuttil

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Induction therapy with interleukin-2 receptor antagonist after intestinal transplantation is associated with reduced acute cellular rejection and improved renal function'. Together they form a unique fingerprint.

Medicine & Life Sciences